E

EryDel S.p.A.

25 employees

Erydel develops technology for drug delivery of pharmacological agents through red blood cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Pharmaceutical

enzyme replacement

ataxia telangiectasia

platform

science and technology

Health Care

red blood cell

orphan drugs

biotech

rare disease

Date founded

2007

FAQ